Status:
NOT_YET_RECRUITING
PuO2 in RenalGuard Pilot Study
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Cardiac Surgery Subjects
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The PuO2 in RenalGuard (PURE) study is planned as a single center, randomized controlled pilot study comparing renal oxygenation during cardiac surgery with cardiopulmonary bypass (CPB) with or withou...
Eligibility Criteria
Inclusion
- Patients ≥18 years of age
- scheduled for cardiac surgery with normothermic CPB
- Estimated glomerular filtration rate ≥50 ml/min as assessed by the CKD-EPI formula
Exclusion
- Patient receiving furosemide at a dose\>100 mg/day orally (or the equivalent dose of an alternative loop diuretic) in the last week
- Patient who cannot be urethrally catheterized for any reason
- Patient already dialysis dependent
- Known or suspected AKI (KDIGO criteria) at the time of screening
- Any condition which, in the judgement of the investigator, might increase the risk to the patient
Key Trial Info
Start Date :
March 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06886191
Start Date
March 17 2025
End Date
December 31 2026
Last Update
March 20 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.